Download Curriculum Vitae

Curriculum Vitae
of
Daryoush Shahbazi-Gahrouei BSc, MSc, PhD
Professor of Medical Physics
Date of Birth: 26th March 1964
Education:
- Diploma of Mathematics and Physics (1980-1983), Shahid Beheshti High
School, Shahrekord, Iran
- Bachelor of Physics (1983-1987), University of Isfahan, Isfahan, Iran
- Master of Science (1987-1991), Medical Physics, University of Tarbiat
Modarres, Tehran, Iran.
- Doctor of Philosophy (1997-2000), Medical Physics, University of Western
Sydney, Sydney, Australia.
Ph.D. Thesis: “Development and Application of New Cancer-Specific Contrast
Agents for Tumour Detection by Magnetic Resonance Imaging”.
Publications:
1. D. Shahbazi-Gahrouei, M. Williams, S. Rizvi, B. J. Allen. In vivo studies of GdDTPA-monoclonal antibody and Gd-porphyrins: potential MR imaging contrast
agents for cancer. J. Magn. Reson. Imaging, 2001; 14:169-174.
2. D. Shahbazi-Gahrouei, M. Williams, B. J. Allen. Gadolinium-cDTPAa
conjugated with melanoma monoclonal antibody 9.2.27 as a melanoma specific MRI
contrast agent. In Proc. 8th ISMRM Meeting in Denver, Colorado, USA, 3-7 April,
2000, p. 2604.
3. D. Shahbazi-Gahrouei, M. Williams, B. J. Allen. In vitro study of relationship
between signal intensity and Gd-DTPA concentration at high magnetic field strength.
Australasian Radilology, 2001: 45(3):298-305.
4. D. Shahbazi-Gahrouei, M. Williams, S. Rizvi, B. J. Allen. Gadolinium-DTPA
conjugated with 9.2.27 monoclonal antibody as a melanoma specific magnetic
resonance imaging contrast agent. In Proc. 6th Experimental Radiation Oncology
Meeting in Sydney, Australia, September, 1999.
5. D. Shahbazi-Gahrouei, M. Williams, S. Rizvi, B. J. Allen. In-vitro studies of
gadolinium-DTPA conjugated with monoclonal antibodies as cancer-specific
magnetic resonance imaging contrast agents. Australas Phys Eng Sci Med,2002;
25(1):31-38.
6. D. Shahbazi-Gahrouei, B. J. Allen. New gadolinium complexes as tumorspecific MR imaging contrast agents for cancer detection in nude mice. In Proc. 10th
ISMRM Meeting in Honolulu, Hawai’i, USA, 18-24 May, 2002, p. 2176.
7. D. Shahbazi-Gahrouei, M. Williams, B. J. Allen. Synthesis and application of
Gd-porpyrins as MR imaging agent for cancer detection. Iranian Biomedical Journal,
2001; 5(2&3): 87-95.
8. D. Shahbazi-Gahrouei, B. J. Allen. New gadolinium-porphyrins: potential MR
imaging contrast agents for cancer detection in nude mice. In Proc. 19th ESMRMB
Meeting in Cannes, France, 22-25 August, 2002, p. 409.
9. D. Shahbazi-Gahrouei.
New metalloporphyrins as potential MR imaging
contrast agents for tumor detection. In Proc. 11th ISMRM Meeting in Toronto,
Ontario, Canada 10-16 July, 2003.
10. D. Shahbazi-Gahrouei, Natural background radiation dosimetry in the highest
altitude region of Iran. Journal of Radiation Research, 2003, 44 (3) :285-287.
11. D. Shahbazi-Gahrouei, Annual Background Radiation in Chaharmahal and
Bakhtiari Province. Iranian Journal of Radiation Research, 2003, 1(2): 87-91.
12. D. Shahbazi-Gahrouei. Possible effect of background radiation on cancer
incidence in Chaharmahal and Bakhtiari province. Iranian Journal of Radiation
Research, 2003, 1(3): 171-174.
13. D. Shahbazi-Gahrouei. Investigation of Gd-DTPA-9.2.27 monoclonal antibody
and porphyrin compounds as cancer-specific MR imaging contrast agents. In Proc.
20th ESMRMB Meeting in Copenhagen, Denmark, 9-12 September, 2004.
14. D. Shahbazi-Gahrouei, M. B. Tavakoli, V. Nazari. GadoliniumHematoporphyrin: new potential MRI contrast agent for detection of breast cancer
cell line (MCF-7). Journal of Research in Medical Sciences, 2005, 10(5): 309-313.
15. D. Shahbazi-Gahrouei. Study of human tissues by nuclear magnetic resonance
(NMR). In Proc. First Iranian Congress of Medical Physics, Tabriz, Iran, May 18-21,
1991.
16. D. Shahbazi-Gahrouei. Measurement of natural background radiation in
Chaharmahal and Bakhtiari province. Shahrekord University of Medical Sciences
Journal, Vol.4, No.3, Autumn 2002, 21-26.
17. D. Shahbazi-Gahrouei. Targeted alpha therapy using radiolabeling of monoclonal
antibody. Shahrekord University of Medical Sciences Journal, Vol.3, No.3, Autumn
2001, 1-8.
18. D. Shahbazi-Gahrouei. Invesigation of relationship between MR imaging signal
intensity and contrast agent at high magnetic field strength. Shahrekord University of
Medical Sciences Journal, Vol.2, No.2, Summer 2000, 1-9.
19. Z. Behroozkia, D. Shahbazi-Gahrouei. Comparison of prescribed dose and
absorbed dose in body treatment fields on patients with Hodgkin and Uterin
adenocarsinoma. Shahrekord University of Medical Sciences Journal, Vol.4, No.1,
Spring 2002, 9-16.
20. D. Shahbazi-Gahrouei. Quality control of the radiological equipment in
Chaharmahal and Bakhtiari hospitals. Shahrekord University of Medical Sciences
Journal, Vol.5, No.4, Winter 2004, 11-18.
21. D. Shahbazi-Gahrouei, Danesh Azar. Investigation of cancers incidence relevant
to radiation in Chaharmahal and Bakhtiari province during five years (1998-2002).
Shahrekord University of Medical Sciences Journal, Vol.6, No.1, Spring 2004, 7-13.
22. Z. Behroozkia, D. Shahbazi-Gahrouei. Investigation of pateints exposure from
common medical X-ray examination in Chaharmahal and Bakhtiari hospitals.
Shahrekord University of Medical Sciences Journal, Vol.7, No.2, Summer 2005, 5763.
23. D. Shahbazi-Gahrouei. Gadolinium-hematoporphyrins as potential MR imaging
contrast agents for detection of breast cancer cell line (MCF-7). In Proc. 22nd
ESMRMB Meeting in Basle, Switzerland, 15-18 September, 2005.
24. D. Shahbazi-Gahrouei, M. Roufeh and M. B. Tavakoli. Gd-DTPA-C595 as a
new MR imaging contrast agents for breast cancer (MCF-7) detection. In Proc. 22nd
ESMRMB Meeting in Warsaw, Poland, 21-23 September, 2006.
25. D. Shahbazi-Gahrouei. Gadolinium-porphyrins: new potential magnetic
resonance imaging contrast agents for melanoma detection. Journal of Research in
Medical Sciences, 2006, 11(4): 217-223.
26. D. Shahbazi-Gahrouei, M. Roufeh and M. B. Tavakoli. GadoliniumDiethylenetriaminepenta-Acetic Acid Conjugated with Monoclonal Antibody as New
Magnetic Resonance Imaging Contrast Agents for Breast Cancer (MCF-7) Detection.
Iranian Biomedical Journal, 2006, 10(4): 209-213.
27. F. Bouzarjomehri, M. H. Zare and D. Shahbazi-Gahrouei. Conventional and
spiral CT dose indices in Yazd general hospitals. Iranian Journal of Radiation
Research, 2006, 3(4): 183-189.
28. D. Shahbazi-Gahrouei. Gadolinium-hematoporphyrins as potential MR imaging
contrast agents for detection of breast cancer cell line (MCF-7). In Proc. 22nd
ESMRMB Meeting in Basle, Switzerland, 15-18 September, 2005.
29. D. Shahbazi-Gahrouei and M. B. Tavakoli. Gd-DTPA-C595 as a new MR
imaging contrast agents for breast cancer (MCF-7) detection. In Proc. 23rd ESMRMB
Meeting in Warsaw, Poland, 21-23 September, 2006.
30. D. Shahbazi-Gahrouei. Dose assessment and radioactivity of the mineral water
resources of Dimeh springs in Chaharmahal and Bakhtiari Province, Iran. In abstract
book of 1st Human, Life and Radiation Conference, Rafsanjan University of Medical
Sciences, 29-31 Oct., 2006, p. 94.
31. F. Bouzarjomehri, D. Shahbazi-Gahrouei and M. H. Zare. Survey of patient
doses from computed tomography (CT) examinations in the area of Yazd, Iran. In
abstract book of 1st Human, Life and Radiation Conference, Rafsanjan University of
Medical Sciences, 29-31 Oct., 2006, p. 49.
32. F. Bouzarjomehri, D. Shahbazi-Gahrouei and M. H. Zare. Survey of
conventional and spiral CT doses in Yazd, Iran. In abstract book of 1st Human, Life
and Radiation Conference, Rafsanjan University of Medical Sciences, 29-31 Oct.,
2006, p. 74.
33. D. Shahbazi-Gahrouei and Ehsan Khodamoradi. Novel MR imaging contrast
agents for detection of HT29/219 cells in mice. In Proc. ISMRM-ESMRMB Annual
Meeting in Berlin, Germany19-25 May, 2007.
34. D. Shahbazi-Gahrouei. Entrance surface dose measurements for routine x-ray
examinations in Chaharmahal and Bakhtiari hospitals. Iranian Journal of Radiation
Research, 2006, 4(1): 29-33.
35. D.Shahbazi-Gahrouei, MB Tavakoli, M. Roufeh and V. Nazari. Assessment of
new Gadolinium compounds as contrast agents for detection of MCF-7 breast cancer
cell line in MRI. Feyz Magazine Vol. 10, No.3, 2006, 16-21.
36. D. Shahbazi-Gahrouei and Ehsan Khodamoradi. Porphyrin-based agents:
potential MR Imaging contrast agents for colorectal (HT29/219) detection in mice.
Journal of Medical Sciences, 2007, 7(6): 1015-1020.
37. F. Bouzarjomehri, M. H. Zare and D. Shahbazi-Gahrouei. Patient dose resulting
from CT examinations in Yazd, Iran. Iranian Journal of Radiation Research, 2006,
4(3): 121-127.
38. D. Shahbazi-Gahrouei, Z. Shahi and K. Ziaei. Dose assessment of salivary
glands in radioiodine therapy. In Proceeding of EANM'07– Annual Congress of the
European Association of Nuclear Medicine, Oct. 13-1, 2007, Copenhagen, Denmark,
Poster 475, S359.
39. Alireza Mehri, D. Shahbazi-Gahrouei and L. Ghaedi. Investigation and
comparison of recording time of steady state evoked potentials using three methods
of Kalman, Ziarani and adaptive, Audiology, 2007, 16(1): 18-24.
40. D. Shahbazi-Gahrouei, Z. Shahi,K. Ziaei and E. Khodamoradi. Estimation of
absorbed dose of salivary glands in radioiodine therapy and its reduction using
pilocarpine. Iranian Journal of Nuclear Medicine, 2007, 15(2): 1-8.
41. D. Shahbazi-Gahrouei, Saeb, M. Dose assessment and radioactivity of the
mineral water resources of Dimeh springs in Chaharmahal and Bakhtiari Province,
Iran. Nukleonika, 2008, 53(1): 31-34.
42. M. B. Tavakoli, D. Shahbazi-Gahrouei, M. Hosseinpour. Dosimetric
characteristics of 137Cs sources used after loading Selectron system by Monte Carlo
method. Iranian Journal of Radiation Research, 2007, 5(3): 147-152.
43. D. Shahbazi-Gahrouei, Z. Shahi. Novel MR imaging contrast agents for cancer
detection. The 6th congress of the Iranian Radiographic Sciences Association
(6ICRSA), April 25-26, 2008, Hotel Homa, Shiraz, Iran.
44. D. Shahbazi-Gahrouei, A. Ebrahiminia, A. Karegar. Investigation of relationship
between exposure with trace element concentrations of radiation workers in Isfahan.
The 6th congress of the Iranian Radiographic Sciences Association (6ICRSA), April
25-26, 2008, Hotel Homa, Shiraz, Iran.
45. E. Raeisi H. Rajabi, D. Shahbazi-Gahrouei, S.M.R Aghamiri, Z. Shahi. Quality
control tests for single-head gamma camera. The 6th congress of the Iranian
Radiographic Sciences Association (6ICRSA), April 25-26, 2008, Hotel Homa,
Shiraz, Iran.
46. D. Shahbazi-Gahrouei, A. Gookizadeh, M. Abdollahi Z. Shahi. Comparison of
conventional radiotherapy techniques with different energies of prostate cancer
treatment, using a designed pelvis phantom. The 6th congress of the Iranian
Radiographic Sciences Association (6ICRSA), April 25-26, 2008, Hotel Homa,
Shiraz, Iran.
47. D. Shahbazi-Gahrouei, Saeb, M. Annual effective dose measurement from
consumption of Dimeh springs in the highest altitude region of Iran. International
Journal of Low Radiation. 2008, 5(1): 49-54.
48. D. Shahbazi-Gahrouei, A. Gookizadeh, M. Abdollahi. Comparison of
conventional radiotherapy techniques with different energies in treating prostate
cancer, employing a designed pelvis phantom. Journal of Medical Sciences, 2008,
8(4): 429-432.
49. D. Shahbazi-Gahrouei, A. Arabpour, S. Kermani, F. Rastgoo. Assessment of
gated single photon emission computerized tomography cardiac wall motion by
using different reconstruction methods and filters in comparison with quantitative
coronary angiography. Journal of Medical Sciences, 2008, 8(4): 342-349.
50. D. Shahbazi-Gahrouei, A. Arabpour, F. Rastgoo, N. Yaghoobi. Comparison of
Reconstructive Methods Using Different Filters to Study Cardiac Wall Motions in
Gated Single Photon Emission Computerized Tomography. Journal of Applied
Sciences. 2009, 9(2): 312-319.
51. A. Ebrahiminia, D. Shahbazi-Gahrouei, A. Karegar, A. Farzan. Relationship
between occupational exposure and concentration of some trace elements in
radiology and radiotherapy workers. JQUMS, 2008, 12(3): 52-57.
52. D. Shahbazi-Gahrouei, P. Bonyadi, M. Moslehi, Z. Shahi. Effects of early
liothyronine consumption after radio-iodine therapy on accumulated dose and
exposure rate in patients with thyroid carcinoma. Iranian Journal of Nuclear
Medicine, 2009, 16(30): 8-15.
53. S. Kermani, M.H. Moradi, H. Abrishami-Moghaddam, H. Saneei, M.J. Marashi,
D. Shahbazi-Gahrouei. Quantitative analysis of left ventricular performance from
sequences of cardiac magnetic resonance imaging using active mesh model.
Computerized Medical Imaging and Graphics (CMIG), 2009, 33: 222-234.
54. M.A. Mosleh-Shirazi, D. Shahbazi-Gahrouei, S. Karbasi, S. Monadi.
Characterization and Monte Carlo simulation of low- and high-perturbation in-vivo
diode dosimeters for 9 MV x-ray. World Congress 2009, IFMBE Proceeding, 2009,
25(I): 731-734.
55. D. Shahbazi-Gahrouei. Novel MR imaging contrast agents for cancer detection.
JRMS, 2009, 14(3): 141-147.
56.
D. Shahbazi-Gahrouei, S. Nikzad, P. Shokrani, Z. Shahi, Sh. Monadi.
Determination of absorbed dose of organs (Thyroid, Sternum, Cervical vertebra) in
thyroid cancer patients following Radioiodine therapy. Iranian Journal of Nuclear
Medicine, 2009, 17(1): 27-33.
57. D. Shahbazi-Gahrouei, Novel MR imaging contrast agents for cancer detection.
In Proc. 26th ESMRMB Meeting in Antalya, Turkey, 1-3 October, 2009.
58. D. Shahbazi-Gahrouei, P. Boniadi, M. Moslehi, Z. Shahi. Investigation of
liothyronine effects on accumulated dose and exposure of thyroid cancer patients in
radioiodine therapy, Isfahan, Iran. In proceeding of European Journal of Nuclear
Medicine and Molecular Imaging, 2009, 36: (Supplementary 2), Poster 565, S420.
59. D. Shahbazi-Gahrouei, S. Nikzad. Determination of organ doses in radioiodine
therapy using medical internal radiation dosimetry (MIRD) method. International
Conference of Radiation Protection in Medicine, RPM, 2010, Varna, Bulgaria, 1-3
September, 2010.
60. D. Shahbazi-Gahrouei. Determination of absorbed dose of organs (Thyroid,
Sternum, Neck vertebra) in thyroid cancer patients under iodine therapy. Medical
Physics and Biomedical Engineering, WC2009, September 7-12, Munich, Germany.
61. D. Shahbazi-Gahrouei. The effect of diagnostic magnetic fields (0.35 T) on sex
hormones and other fertility parameters of adult male rats. 6th International
Workshop on Biological Effects of Electromagnetic Fields, 10-14 October 2010,
Bodrum, Turkey.
62. D. Shahbazi-Gahrouei, M. Abdolahi. Investigation of relationship between
background exposure with trace element concentrations of hot springs workers in
Mahalat. 1st Reseacrh Festival of the Student Radiological Sciences, 7-8 October,
2010, Shiraz University of Medical Sciences, Sina and sadra Hall.
63. Gholam Reza Amiri, Mohammad Hasan Yousefi, M. R. Aboulhassani, M. H.
Keshavarz, D. Shahbazi-Gahrouei, Soheil. Fatahian and M. Alahi. Radar
Absorption and Q-Factor of Ni0.7Zn0.3Fe2O4 Nanoparticles. Digest Journal of
Nanomaterials and Biostructures. 2010, 5(3): 719-725.
64. D. Shahbazi-Gahrouei, F, Kouhian, M. Kouhian, M. Sadeghi. Effects of MRI on
sex hormones and other fertility parameters in adult male rats. Journal of Shahrekord
University of Medical Sciences (JSKUMS). 2011, 13(1): 36-41.
65. D. Shahbazi-Gahrouei and S. Nikzad, Determination of organ doses in
radioiodine therapy using medical internal radiation dosimetry (MIRD) method.
Iranian Journal of Radiation Research, 2011, 8(4): 249-252.
66. D. Shahbazi-Gahrouei, M. Nazem, M. Sharbafchizadeh, M. S. Jafarpishehfard.
The average of cumulative radiation dose in neonates in the neonatal surgery ward
due to diagnostic and therapeutic radiologic procedures during the admission period.
Journal of Isfahan Medical School (JIMS), 2011, 129(40): 1-8.
67. Soheil Fatahian, D. Shahbazi-Gahrouei, Majid Pouladain, Mohammad Hassan.
Yousefi, Gholam Reza Amiri, Zahra Shahi, H. Jahanbakhsh. Preparation and
magnetic properties investigation of Fe3O4 nanoparticles 99mTc labeled and Fe3O4
nanoparticles DMSA coated. Digest Journal of Nanomaterials and Biostructures.
2011, 6(3): 1161-1165.
68. D. Shahbazi-Gahrouei, Saba Ayat. Comparison of three method of calculation,
experimental and Monte Carlo simulation to determine absorbed organs dose in
thyroid cancer patients following radioiodine therapy. European Journal of Nuclear
Medicine and Molecular Imaging, October 2011, 38 (Supplement: 2), S434-S434.
69.
D. Shahbazi-Gahrouei, S. Nikzad. Determination of organ doses in radioiodine
therapy using medical internal radiation dosimetry (MIRD) method. International
Conference of Radiation Protection in Medicine, RPM, 2010, Varna, Bulgaria, 1-3
September, 2010.
70. D. Shahbazi-Gahrouei. The effect of diagnostic magnetic fields (0.35 T) on sex
hormones and other fertility parameters of adult male rats. 6th International Workshop
on Biological Effects of Electromagnetic Fields, 10-14 October 2010, Bodrum
Turkey.
71. D. Shahbazi-Gahrouei. Non-Ionizing Radiation and Health Hazards. The 1st
MEFOMP International Conference of Medical Physics, Shiraz, Iran, November 2-4,
2011.
72. D. Shahbazi-Gahrouei and Saba Ayat. Comparison of three methods of
calculation, experimental and Monte Carlo simulation in investigation of organ doses
(Thyroid, Sternum, Cervical vertebra) in Radioiodine Therapy. 1st MEFOMP
International Conference of Medical Physics, Shiraz, Iran, November 2-4, 2011.
73. F. Kouhiyan, D. Shahbazi and M Kouhiyan. Change of cortisol concentration in
rats exposed to magnetic resonance imaging. 1st MEFOMP International Conference
of Medical Physics, Shiraz, Iran, November 2-4, 2011.
74. D. Shahbazi-Gahrouei, M. Abdolahi, F. Hasanzadeh, F. Firouzian S. Zarkesh,
B.J. Allen. Detection of PSMA-Expressing prostate cancer by J591 Mab-conjugated
SPIONs using MRI. 1st MEFOMP International Conference of Medical Physics,
Shiraz, Iran, November 2-4, 2011.
75. D. Shahbazi-Gahrouei and M. Salimi-Afjani. The application of Excimer laser in
refractive errors correction and compared with glasses and contact lens. 1st MEFOMP
International Conference of Medical Physics, Shiraz, Iran, November 2-4, 2011.
76. D. Shahbazi-Gahrouei, Mostafa Khosravi, Keyvan Jabbari and Rouhollah
Gheisari. Measurement of photo-neutron dose in the linear accelerator in radiation
therapy section of Seyed-Alsholada Hospital, Isfahan, Iran. Journal of Isfahan
Medical School (JIMS), 2012, 166(29): 1-10.
77. D. Shahbazi-Gahrouei, Seyed Mohammad Javad Mortazavi, Hamid Nasri, Azar
Baradaran, Milad Baradaran-Ghahfarokhi, Hamid Reza Baradaran-Ghahfarokhi.
Mobile phone radiation interferes laboratory immunoenzymometric assays: Example
chorionic gonadotropin assays. Pathophysiology, 2012, 19:43-47.
78. D. Shahbazi-Gahrouei and Milad Baradaran-Ghahfarokhi. Investigation of
patient dose from common radiology examinations in Isfahan, Iran. Advanced
Biomedical Research, 2012, May,1:11.
79. Soheil Fatahian, D. Shahbazi-Gahrouei, Majid Pouladain, Mohammad Hassan.
Yousefi, Gholam Reza Amiri, Ali Noori. Biodistribution and toxicity assessment of
radiolabeled and DMSA coated ferrite nanoparticles in mice. Journal of
Radioanalytical and Nuclear Chemistry, 2012, 293(3): 915-921.
80. D. Shahbazi-Gahrouei, Mohammad Abdolahi. The correlation between high
background radiation and blood level of the trace elements (copper, zinc, iron and
magnesium) in workers of Mahallat’s hot springs. Advanced Biomedical Research,
2012, August, 1:64.
81. D. Shahbazi-Gahrouei, Samaneh Setayandeh and Mehrdad Gholami. A review
on comparison of natural radiation in Iran with other countries. International Journal
of Low Radiation, 2013, 9(1): 1-11. DOI: 10.1504/IJLR.2013.054163
82. D. Shahbazi-Gahrouei, Mohsen Cheki, Masoud Moslehi. Comparison of organ
absorbed doses in patients from 99mTc-diphosphonate with the MIRD data of report
no.13. European Review for Medical and Pharmacological Sciences, 2012.
83. D. Shahbazi-Gahrouei and Saba Ayat. Comparison of three methods of
calculation, experimental and Monte Carlo simulation in investigation of organ doses
(Thyroid, Sternum, Cervical vertebra) in Radioiodine Therapy. Journal of Medical
Signals and Sensors, 2012, 2(3): 149-152.
84. D. Shahbazi-Gahrouei and Milad Baradaran-Ghahfarokhi. Assessment of
Entrance Surface Dose and Cancer Risk from Common Radiology Examinations in
Iran. Radiation Protection Dosimetry, 2013, 154(3):308-313.
85. Mostafa Khosravi, D. Shahbazi-Gahrouei, Keyvan Jabbari, Milad BaradaranGhahfarokhi, Ruhollah Gheisari, Behnam Amiri. Photoneutron Contamination from
an 18 MV Saturne Medical Linear Accelerator in Treatment Room: Monte-Carlo
Simulation. Radiation Protection Dosimetry, 2013, 156(3):356-363.
86. D. Shahbazi-Gahrouei, Farideh Koohian, M Koohian. Changes of cortisol and
glucose concentrations in rats exposed to MR imaging field. Journal of Biomedical
Physics and Engineering (JBPE), 2013, 3(1):9-12.
87. D. Shahbazi-Gahrouei, Mohsen Cheki, Masoud Moslehi. Estimation of organ
absorbed doses in patients from 99mTc-diphosphonate using the data of MIRDose
software. Journal of Medical Signals and Sensors, 2012, 2(4): 231-233.
88. Mohammad Abdolahi, D. Shahbazi-Gahrouei, Sophie Laurent, Corine Sermeus,
Farzin Firozan, Barry J. Allen, Sebastian Boutry, Robert N. Muller. Synthesis and in
vitro evaluation of MR molecular imaging probes using J591 mAb-conjugated
SPIONs for specific detection of prostate cancer. Contrast Media and Molecular
Imaging (CMMI), 2013, 8(2): 175-184.
89. Mehdi Mirzaei, Mohammadali Mohagheghi, D. Shahbazi-Gahrouei, Alireza
Khatami. Novel nanosized Gd3+-ALGD-G2-C595: In vivo dual selective MUC-1
positive tumor molecular MR imaging and therapeutic agent. Journal of
Nanomedicine and Nanotechnology, 2012, 3(7): 1000147.
90. Mohammad Amin Mosleh-Shirazi, Sareh Karbasi, D. Shahbazi-Gahrouei and
Shahram Monadi. A Monte Carlo and experimental investigation of the dosimetric
behaviour of low- and medium-perturbation diodes for entrance in vivo dosimetry in
megavoltage photon beams. Journal of Applied and Clinical Medical Physics
(JACMP), 2012, 13(6): 326-338.
91. D. Shahbazi-Gahrouei, Mehrdad Gholami and Samaneh Setayandeh. A review
on natural background radiation. Advanced Biomedical Research, 2013, 2(3):65.
92. D. Shahbazi-Gahrouei, Mohammad Abdolahi, Sayyed-Hamid Zarkesh, Sophie
Laurent, Corine Sermeus, Cordula Gruettner. Functionalized magnetic nanoparticles
for the detection and quantitative analysis of cell surface antigen. Biomed Research
International, 2013, 2013: 349408.
93. Mehdi Mirzaei, D. Shahbazi-Gahrouei, Mohammadali Mohagheghi. Synthesis
and development of Gd3+-ALGDG2-C595 as MR imaging contrast agent. Journal of
Biomaterials and Nanobiotechnology, 2013, 4: 22-29.
94. Mehdi Mirzaei, Mohammadali Mohagheghi, D. Shahbazi-Gahrouei, Alireza
Khatami. Gd3+-anionic linear globular dendrimer-G2-C595 a novel nanoprobe for MR
imaging: An in vitro study. Journal of Biomolecular Research and Therapeutics,
2012, 1(2): 1000103.
95. D. Shahbazi-Gahrouei, Mohammad Abdolahi. A novel method for quantitative
analysis of anti-MUC1 expressing ovarian cancer cell surface based on magnetic cell
separation. Journal of Medical Sciences, 2102, 12(8): 256-266.
96. D. Shahbazi-Gahrouei, Mojtaba Karbalae, Habib Moradi, Milad BaradaranGhahfarokhi. Health Effects of Living near Mobile Phone Base Transceiver Station
(BTS) Antennae: A Report from Isfahan, Iran. Electromagnetics Biology and
Medicine, 2014, 33(3): 206-210.
97. Marzieh Salimi, D. Shahbazi-Gahrouei, Saied Karbasi, Saied Kermani, Shahnaz
Razavi. Effect of extremely low-frequency (50 Hz) field on proliferation rate of
human adipose-derived mesenchymal stem cells. Journal of Isfahan Medical School
(JIMS), 2013, 31(232): 1-17.
98. Sohrab Manouchehri, Zeinab Ghasemian, D. Shahbazi-Gahrouei, Mohammad
Abdolahi. Synthesis and characterization of cobalt-zinc ferrite nanoparticles coated
with DMSA. ChemXpress, 2013, 2(3): 147-152.
99. D. Shahbazi-Gahrouei, Mohammad Abdolahi. Superparamagnetic iron oxideC595: Potential MR imaging contrast agents for ovarian cancer detection. Journal of
Medical Physics, 2013, 38(4): 198-204.
100. D. Shahbazi-Gahrouei, Mohammad Abdolahi. Detection of MUC1-expressing
ovarian cancer by C595 monoclonal antibody conjugated SPIONs using MR imaging.
The Scientific World Journal, 2013: (2013), Article ID: 609151, 7 pages.
101. Mohsen Cheki, D. Shahbazi-Gahrouei, Masoud Moslehi. Determination of organ
absorbed doses in patients following bone scan with using of MIRD method. Iranian
South Medical Journal (ISMJ), 2013, 16(5): 296-303.
102. D. Shahbazi-Gahrouei , Sohrab Manouchehri , Zeinab Ghasemian, Mohammad
Abdolahi. Synthesis and characterization of Cobalt-zinc ferrite magnetic
nanoparticles coated with DMSA. In Proc. 30th ESMRMB Annual Scientific Meeting,
October 3-5, Toulouse, France, p.602.
103. D. Shahbazi-Gahrouei, Mohsen Cheki, Masoud Moslehi. Assessment of organ
absorbed dose in patients following bone scan with technetium-99m-labeled
methylene diphosphonate (MDP) using of MIRD method. In Proceeding of EANM'13
- Annual Congress of the European Association of Nuclear Medicine - October 19 -
23, 2013 - Lyon, France, p.426.
104. D. Shahbazi-Gahrouei, Mohammad Abdolahi. Superparamagnetic iron oxidemonoclonal antibody: potential MR imaging contrast agents for ovarian cancer. In
Proc. 30th ESMRMB Annual Scientific Meeting, October 3-5, Toulouse, France,
p.496.
105. Shahnaz Razavi, Marzieh Salimi, D. Shahbazi-Gahrouei , Saeed Karbasi, Saeed
Kermani. Extremely low-frequency electromagnetic field influences the survival and
proliferation effect of human adipose derived stem cells. Advanced Biomedical
Research, 2014, 3(1):25.
106. Masoud Moslehi, Masoumeh Rahimi, Bita Moradi Khaniabadi, D. ShahbaziGahrouei. Investigation of the effect of Neck physical examination and signing
thyroid nodules by Lead marker on 99mTcO4 thyroid scan results in patients of Seyyed
Alshohada Hospital Nuclear Medicine Center, Isfahan, 2013. Journal of Isfahan
Medical School (JIMS), 2014, 31(259): 1-9.
107. Shahbazi-Gahrouei D, Ghasemian Z, Abdolahi M, Manouchehri S, Javanmard
SH, Dana N. In vitro Evaluation of Cobalt-Zinc Ferrite Nanoparticles Coated with
DMSA on Human Prostate Cancer Cells. J Mol Biomark Diagn, 2013, 4(3):154. doi:
10.4172/2155-9929.1000154.
108. Shahbazi-Gahrouei D. Radiobiological modeling in radiation oncology. Journal
of Radiobiology, 2014, 1(1): 17-18.
109. Nasri H, Nasri P, Baradaran-Ghahfarokhi M, Shahbazi-Gahrouei D, Fattahi-Asl
J. Mobile phone radiation and human serum components: A short literature review on
recent findings. Life Science Journal, 2014, 11(9): 426-431.
110. Arab Z, Shahbazi-Gahrouei D, …. Multiple MTS assay as the alternative
method for determining survival fraction of the irradiated human intestinal colon
cancer cells (HT-29).
111. Shahbazi-Gahrouei D, Shiri Leila, Alaei Hojjatollah, Naghdi Naser, Kermani
Saieed, Afrouzi Hossein Kiani Ali, Akbari Mojtaba. The effect of extremely lowfrequency magnetic fields on the level of serotonin metabolite in the Raphe nuclei of
adult male rat. Journal of Isfahan Medical School (JIMS), 2014, 32(298): …..
112. Shiri Leila, Shahbazi-Gahrouei D, Alaei Hojjatollah, Naghdi Naser, Kermani
Saieed, Afrouzi Hossein. The effect of extremely low frequency continues magnetic
field on the 5-HIAA in the Raphe nucleus of rat. Bioelectromagnetics,
113. D. Shahbazi-Gahrouei, Mohammad Abdolahi. Investigation of association
between high background radiation exposure with trace element concentrations’
(Copper, Zinc, Iron and Magnesium) of hot springs workers blood in Mahalat.
Iranian South Medical Journal (ISMJ), 2014, 17(4): 687-694.
114. Nadealian Dastjerdi Fariba, Shahbazi-Gahrouei D, Alamatsaz Mohammd Hassan,
Baradaran-Ghahfarokhi Milad. Photoneutron shielding design for an 18 MV Saturne
20 medical linear accelerator. Journal of Isfahan Medical School (JIMS), 2014, (…):
…..
115. Shahbazi-Gahrouei D, Gholami Mehrdad. The effect of gel homogeneity on dose
response in low density polymer gel dosimeter.
116. Shahbazi-Gahrouei D, Gholami Mehrdad. Dose response evaluation of a low
density anoxic polymer gel dosimeter using MRI. International Journal of Radiation
Research (IJRR), …..
117. Shahbazi-Gahrouei D, Gholami Mehrdad. Does nitrogen gas bubbled through a
low density polymer gel dosimeter solution affect the polymerization process?
Advanced Biomedical Research, 2014, ..(…): …
118. D. Shahbazi-Gahrouei, Shahnaz Razavi, Marzieh Salimi. Effect of ELF field on
proliferation rate of human adipose-derived mesenchymal stem cells.